M. Sara Rosenthal, Ph.D., bestselling author of The Thyroid Sourcebook (recommended by The New York Times), The Thyroid Sourcebook for Women and The Hypothyroid Sourcebook has just published The Thyroid Cancer Book, the only consumer book to date devoted to thyroid cancer. A thyroid cancer survivor herself, Rosenthal wrote the book she wishes she'd had when diagnosed in 1983. The Thyroid Cancer Book explains all forms of thyroid cancer and its treatment in plain language. It was written in consultation with the leading medical experts on thyroid cancer in North America, and is the only book of its kind in the world. It includes extensive information on: Significant risk factors for developing the disease, and how to find and investigate lumps in the neck Papillary and follicular thyroid cancers, as well as the less common medullary and anaplastic cancers Treatment options, surgery and radioactive iodine Post-treatment follow up, whole body scans and Thyrogen Self-healing and complementary therapies The emotional impact of cancer on families and loved ones Palliative care While thyroid cancer accounts for roughly two percent of all cancers, it's among the fastest growing cancers in incidence. Its causes in North America are associated with fallout from nuclear testing in the American midwest, and environmental causes which Rosenthal also writes about in detail. Recommended by Johns Hopkins Thyroid Tumor Center, The Thyroid Foundation of America, The American Foundation for Thyroid Patients, The Thyroid Foundation of Canada, CancerHelpUK, and thyroid cancer patients from both Thyca and Thry'Vors.

This atlas is the offspring of the “The National Cancer Institute (NCI) Thyroid Fine Needle Aspiration (FNA) State of the Science Conference,” hosted by the NCI and organized by Dr. Andrea Abati. Preparations for the conference began 18 months earlier with the designation of a steering committee and the establishment of a dedicated, p- manent web site. The meeting took place on October 22 and 23, 2007 in Bethesda, Maryland and was co-moderated by Susan J. Mandel and Edmund S. Cibas. The discussions and conclusions regarding terminology and morphologic criteria 1, 2 from the meeting were summarized in publications by Baloch et al. and form the framework for this atlas. The atlas is organized by the general categories of “Nondiagnostic,” “Benign,” “Follicular Neoplasm/Suspicious for a Follicular Neoplasm”, “Suspicious for Malignancy,” and “Malignant,” and it includes the defi- tions and morphologic criteria of these categories as set forth by Baloch et al. The majority of the conference participants also agreed on a category of “undetermined significance,” which is incorporated in this atlas (Chap. 4). It is critical that the cytopathologist communicate thyroid FNA interpretations to the referring physician in terms that are succinct, unambiguous, and helpful clinically. We recognize that the terminology used here is a flexible framework that can be modified by individual laboratories to meet the needs of their providers and the patients they serve.

The American Joint Committee on Cancer's Cancer Staging Manual is used by physicians throughout the world to diagnose cancer and determine the extent to which cancer has progressed. All of the TNM staging information included in this Sixth Edition is uniform between the AJCC (American Joint Committee on Cancer) and the UICC (International Union Against Cancer). In addition to the information found in the Handbook, the Manual provides standardized data forms for each anatomic site, which can be utilized as permanent patient records, enabling clinicians and cancer research scientists to maintain consistency in evaluating the efficacy of diagnosis and treatment. The CD-ROM packaged with each Manual contains printable copies of each of the book’s 45 Staging Forms.

Edited by Clark (surgery, University of California, San Francisco, and Mount Zion Medical Center) and Noguchi (Noguchi Thyroid Clinic and Hospital Foundation), this volume explains the rationale behind currently popular treatments and clarifies the controversies surrounding the diagnosis and immediate management of patients with the disease. Presenting contributions from an international group of authorities, it contains critical outcome data, information on new diagnostic modalities, management strategies, illustrated surgical techniques, and the latest advances in molecular biology.

Utilizing the most current evidence, this practical book is the first publication of its kind to focus exclusively on the clinical and laboratory evaluation and therapy of thyroid nodules, including advances in evaluation and controversies in management. Opening with chapters presenting the epidemiology, history, laboratory and clinical evaluation of thyroid nodules, the use of radioactive isotope ultrasound and CT scanning in diagnosis is then described. The interpretation of thyroid cytology following fine needle aspiration (FNA) biopsies and the use of molecular markers are discussed in detail, as is the controversial use of thyroxine therapy. Following a presentation of the common and minimally invasive surgical approaches to thyroid nodules, chapters on multinodal goiters, incidentalomas and thyroid nodules in children round out the presentation. Written and edited by leading US and international thyroidologists, Thyroid Nodules is a useful, state-of-the-art text for endocrinologists, surgeons, and primary care physicians.

This is the third updated edition of the book on thyroid cancer for patients with thyroid cancer or for family or friends of patients with thyroid cancer. The two senior editors are internationally renowned nuclear medicine physician and endocrinologist along with the founder and CEO of the largest thyroid cancer support group in the world. It has 44 chapters, 8 appendices, over 500 pages, and 37 contributors.